Skip to content

E85.82

Billable

Wild-type transthyretin-related (ATTR) amyloidosis

HCC Category Mapping

V28HCC 50Glycogen/Amino-Acid/Other Metabolic Disorders
0.289
V24HCC 23Other Significant Endocrine and Metabolic Disorders
0.230
ESRDHCC 23Other Significant Endocrine and Metabolic Disorders
0.000

What This Code Means

A hereditary disease where abnormal transthyretin protein accumulates in the body, particularly affecting the heart and nerves. This is the most common form of hereditary amyloidosis.

Coding Tips

  • Wild-type ATTR (formerly called senile systemic amyloidosis) occurs in elderly patients without genetic mutations
  • Document whether this is hereditary or wild-type variant, as treatment approaches differ significantly

Clinical Significance

Wild-type ATTR amyloidosis (formerly senile cardiac amyloidosis) is an increasingly recognized cause of heart failure in elderly patients, caused by age-related misfolding of normal transthyretin protein. The availability of disease-modifying therapy (tafamidis) has made accurate diagnosis and coding essential for treatment access.

Documentation Requirements

  • Confirmed ATTR amyloidosis diagnosis (cardiac MRI, technetium pyrophosphate scan, or tissue biopsy)
  • Documentation that this is WILD-TYPE (not hereditary/mutant) ATTR — negative TTR gene testing
  • Cardiac involvement assessment (echocardiography, cardiac biomarkers, NT-proBNP)
  • Functional status and NYHA class
  • Current treatment (tafamidis, heart failure management)
  • Exclusion of hereditary ATTR by genetic testing

Commonly Confused Codes

Code Hierarchy

Open E85.82 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.